|
AU2013205487A1
|
|
Therapeutic and diagnostic agents
|
|
US2010303819A1
|
|
Dcl-1 and uses thereof
|
|
US2010111980A1
|
|
Binding partners of antibodies specific for dendritic cell antigens
|
|
AU2005313857A1
|
|
Binding partners of antibodies specific for dendritic cell antigens
|
|
US2007184036A1
|
|
Isolated cd4+ t cells defined by cmrf-35
|
|
WO2005042729A1
|
|
Isolated cd4+ t cells defined by cmrf-35 and cd45ro
|
|
WO2005027933A1
|
|
Unsaturated phosphatidylcholines and uses thereof
|
|
CA2495408A1
|
|
A method of immunomodulation
|
|
AU2002953238A0
|
|
In vitro immunization
|
|
AU2002953223A0
|
|
Novel therapeutic molecules and uses thereof
|
|
AU2002952993A0
|
|
Therapeutic and diagnostic agents
|
|
EP1458406A1
|
|
A method of treatment and agents useful for same
|
|
AU2002952098A0
|
|
A method of treatment and agents useful for same-ii
|
|
AU2002951082A0
|
|
Therapeutic cellular agents
|
|
AU2002950779A0
|
|
A method of immunomodulation
|
|
AU2002950778A0
|
|
A method of characterizing dendritic cells
|
|
US2003082707A1
|
|
Dendritic cell receptor
|
|
AUPR974101A0
|
|
Novel polynucleotides and uses therefor
|
|
AUPR909801A0
|
|
A method for culturing cells
|
|
AUPR845601A0
|
|
A method of treatment and agents useful for same
|
